跳至主要内容

Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study)

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53238#.VLh24MnQrzE

ABSTRACT
Background: Treatment for postprandial glycemia using rapid-acting insulin analogues sometimes resulted in preprandial hypoglycemia or weight gain. Objective: This study evaluated the efficacy and safety of switching bolus insulin from insulin lispro (Lis) to insulin glulisine (Glu) in patients with inadequately controlled diabetes on intensive insulin therapy with Lis and glargine (Gla). Methods: Seventy-two outpatients with inadequate glycemic control (glycated hemoglobin [HbA1c] ≥7.0%, glycated albumin [GA] ≥20%) on intensive insulin therapy comprising Lis and Gla for ≥24 weeks were enrolled. We switched treatment from Lis to Glu with a stepwise increase in the dose by 1 unit per meal to obtain a GA level of ≤20% for 24 weeks, and the efficacy and safety were evaluated. Patients’ treatment satisfaction was also evaluated using the Diabetes Treatment Satisfaction Questionnaire (DTSQ) after the treatment. Results: After switching from Lis to Glu, both HbA1c and GA levels significantly lowered from 8.26% ± 0.13% to 7.71% ± 0.13% (P < 0.01) and from 23.9% ± 1.8% to 21.4% ± 1.9% (P < 0.01), respectively. Furthermore, switching from Lis to Glu improved patients’ treatment satisfaction; scores for 7 of the 8 items, such as “satisfaction” and “convenience” were significantly improved (P < 0.001), with no significant change in the scores for “improvement of hypoglycemia” (P = 0.91). Conclusions: Our present study suggests that switching bolus insulin from Lis to Glu by the addition of 1 unit of Glu per meal may be a useful treatment option for patients with inadequate glycemic control receiving intensive insulin therapy with Lis and Gla.
 
Cite this paper
Bando, Y. , Shima, K. , Aoki, K. , Kanehara, H. , Hisada, A. , Okafuji, K. , Toya, D. and Tanaka, N. (2015) Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study). Journal of Diabetes Mellitus, 5, 28-35. doi: 10.4236/jdm.2015.51004.
 
References
[1]Stamler, J., Vaccaro, O., Neaton, J.D. and Wentworth, D. (1993) Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16, 434-444. http://dx.doi.org/10.2337/diacare.16.2.434
 
[2]Haffner, S.M., Lehto, S., Rönnemaa, T., Pyörälä, K. and Laakso, M. (1998) Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine, 339, 229-234.
http://dx.doi.org/10.1056/NEJM199807233390404
 
[3]The DECODE Study Group (1999) Glucose Tolerance and Mortality: Comparison of WHO and American Diabetes Association Diagnostic Criteria. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe. Lancet, 354, 617-621.
 
[4]Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T. and Sekikawa, A. (1999) Impaired Glucose Tolerance Is a Risk Factor for Cardiovascular Disease, But Not Impaired Fasting Glucose. The Funagata Diabetes Study. Diabetes Care, 22, 920-924. http://dx.doi.org/10.2337/diacare.22.6.920
 
[5]Donahue, R.P., Abbott, R.D., Reed, D.M. and Yano, K. (1987) Postchallenge Glucose Concentration and Coronary Heart Disease in Men of Japanese Ancestry. Honolulu Heart Program. Diabetes, 36, 689-692. http://dx.doi.org/10.2337/diab.36.6.689
 
[6]2011 Guideline for Management of PostMeal Glucose in Diabetes. www.idf.org
 
[7]Holman, R.R., Farmer, A.J., Davies, M.J., et al. (2009) Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes. The New England Journal of Medicine, 361, 1736-1747.
http://dx.doi.org/10.1056/NEJMoa0905479
 
[8]Daikubara, H., Kikuti, T. and Ishida, T. (2011) Shinyaku to Rinsho, 60, 758-765 (in Japanese).
 
[9]Pouwer, F., Snoek, F.J., van der Ploeg, H.M., Heine, R.J. and Brand, A.N. (1998) A Comparison of the Standard and the Computerized Versions of the Well-Being Questionnaire (WBQ) and the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Quality of Life Research, 7, 33-38.
http://dx.doi.org/10.1023/A:1008832821181
 
[10]Luzio, S., Peter, R., Dunseath, G.J., Mustafa, L. and Owens, D.R. (2008) A Comparison of Preprandial Insulin Glulisine versus Insulin Lispro in People with Type 2 Diabetes over a 12-h Period. Diabetes Research and Clinical Practice, 79, 268-275. http://dx.doi.org/10.1016/j.diabres.2007.11.013
 
[11]Plank, J., Wutte, A., Brunner, G., Siebenhofer, A., Semlitsch, B., Sommer, R., et al. (2002) A Direct Comparison of Insulin Aspart and Insulin Lispro in Patients with Type 1 Diabetes. Diabetes Care, 25, 2053-2057. http://dx.doi.org/10.2337/diacare.25.11.2053
 
[12]Homko, C., Deluzio, A., Jimenez, C., Kolaczynski, J.W. and Boden, G. (2003) Comparison of Insulin Aspart and Lispro: Pharmacokinetic and Metabolic Effects. Diabetes Care, 26, 2027-2031.
http://dx.doi.org/10.2337/diacare.26.7.2027
 
[13]Garg, S.K., Rosenstock, J. and Ways, K. (2005) Optimized Basal-Bolus Insulin Regimens in Type 1 Diabetes: Insulin Glulisine versus Regular Human Insulin in Combination with Basal Insulin Glargine. Endocrine Practice, 11, 11-17. http://dx.doi.org/10.4158/EP.11.1.11
 
[14]Becker, R.H. and Frick, A.D. (2008) Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine. Clinical Pharmacokinetics, 47, 7-20. http://dx.doi.org/10.2165/00003088-200847010-00002
 
[15]Garg, S.K., Ellis, S.L. and Ulrich, H. (2005) Insulin Glulisine: A New Rapid-Acting Insulin Analogue for the Treatment of Diabetes. Expert Opinion on Pharmacotherapy, 6, 643-651.
http://dx.doi.org/10.1517/14656566.6.4.643
 
[16]Becker, R.H., Frick, A.D., Burger, F., Potgieter, J.H. and Scholtz, H. (2005) Insulin Glulisine, a New Rapid-Acting Insulin Analogue, Displays a Rapid Time-Action Profile in Obese Non-Diabetic Subjects. Experimental and Clinical Endocrinology & Diabetes, 113, 435-443.
http://dx.doi.org/10.1055/s-2005-865806
 
[17]Heise, T., Nosek, L., Spitzer, H., Heinemann, L., Niemöller, E., Frick, A.D. and Becker, R.H.A. (2007) Insulin Glulisine: A Faster Onset of Action Compared with Insulin Lispro. Diabetes, Obesity and Metabolism, 9, 746-753. http://dx.doi.org/10.1111/j.1463-1326.2007.00746.x
 
[18]Sakura, N., Omura, M., Oda, E. and Saito, T. (2011) Converse Contributions of Fasting and Postprandial Glucose to HbA1c and Glycated Albumin. Diabetology International, 2, 162-171.
http://dx.doi.org/10.1007/s13340-011-0036-9
 
[19]Imai, T., Oikawa, Y. and Shimada, A. (2007) Improved Monitoring of the Hyperglycemic State in Type 1 Diabetes Patients by Use of the Glycoalbumin/HbA1c Ratio. The Review of Diabetic Studies, 4, 44-48. http://dx.doi.org/10.1900/RDS.2007.4.44
 
[20]Higgins, T., Saw, S., Sikaris, K., Wiley, C.L., Cembrowski, G.C., Lyon, A.W., et al. (2009) Seasonal Variation in Hemoglobin A1c: Is It the Same in both Hemispheres? Journal of Diabetes Science and Technology, 3, 668-671. http://dx.doi.org/10.1177/193229680900300408
 
[21]DeSalvo, D. and Buckingham, B. (2013) Continuous Glucose Monitoring: Current Use and Future Directions. Current Diabetes Reports, 13, 657-662.                                                                                eww150116lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文